FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to a liquid medicinal agent for injections suitable for use in oncology. New liquid medicinal agent for injections contains 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl) cytosine or its pharmaceutically acceptable salt selected from methanesulphonate and hydrochloride, in concentration of 1 to 50 mg/ml, polyatomic alcohol with molecular weight equal to or less than 100, in concentration of 0.5 to 10 wt. %, selected from glycerine, propylene glycol or 1,3-butane diol, and water.
EFFECT: what is offered is a new effective anti-tumour drug preparation that does not generate precipitation during the production process.
6 cl, 4 tbl, 39 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SALT OF 1-(2-DEOXY-2-FLUORO-4-THIO-BETA-D-ARABINOFURANOZIL)CYTOSINE | 2013 |
|
RU2600734C2 |
| ANTITUMOR AGENT, ANTITUMOR ENHANCER AND ANTITUMOR KIT | 2017 |
|
RU2752172C2 |
| NOVEL STABLE CRYSTALS OF 1-(2-β-D-ARABINOFURANOSYL)CYTOSINE MONOHYDRATE | 2010 |
|
RU2538593C2 |
| NEW DERIVATIVES OF PEG | 2015 |
|
RU2697551C2 |
| BATH FOR ELECTROPLATING OF COPPER-NICKEL ALLOY AND PROCEDURE FOR APPLICATION OF GALVANIC COATING | 2013 |
|
RU2588894C2 |
| PREPARATION FOR OUTWARD SKIN APPLICATION CONTAINING TRITERPENIC ACID | 2007 |
|
RU2429829C2 |
| PYRIMIDINE NUCLEOSIDES, METHODS OF SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1991 |
|
RU2116306C1 |
| 2-0-SULFONATES OF METHYL 5-0-BENZYL-3-FLUORO-3-DEOXY-D ARABINOSE AS INTERMEDIATE PRODUCTS IN SYNTHESIS OF BIOLOGICALLY ACTIVE 3-FLUORO-3-DESOXYRIBONUCLEIC OSIDES | 0 |
|
SU1521739A1 |
| METHOD OF PREPARING BETA-ANOMER ENRICHED NUCLEOSIDES | 1993 |
|
RU2131880C1 |
| BATH FOR ELECTROLYTIC COATING WITH COPPER-NICKEL ALLOYS | 2015 |
|
RU2666391C1 |
